Following on the release of the first comprehensive analysis of the global impact of AMR, published in The Lancet in late January 2022, the GCOA paper aims to demystify the terminology and clearly lay out the global threat posed by rising drug resistance and accompanying lack of effective new drugs in the development pipeline. The paper…

The roundtable identified promising pathways for OECD countries to galvanize new innovations to predict, prevent, and address age-related health challenges, mitigate the costs of these challenges, and ensure fiscal sustainability in a world of more old than young. While the roundtable participants were clear on the importance of access and reimbursement for healthy ageing in…

On November 22, 2021, Biogen, the Global Coalition on Aging (GCOA) and Alzheimer’s Disease International (ADI) launched a report evaluating 10 European countries on how well they are addressing Alzheimer’s disease. The development costs of the 2021 Alzheimer’s Innovation Readiness Index (AIRI) were funded by Biogen. The 2021 AIRI was created in partnership with GCOA…

More than 2.2 billion people worldwide have a visual impairment or vision loss, and this number is poised to grow because the risk increases with age. Over 90% of vision impairment worldwide is avoidable. However, an estimated 802 million older people across the world are living with preventable vision loss but have no access to…

In addition to GCOA leadership, contributors to the video include Dr. Mike Devoy, Chief Medical Officer and Executive VP of Medical Affairs & Pharmacovigilance, Bayer; Dr. Nir Barzilai, Director of the Einstein-Institute for Aging Research and Professor of Medicine and Genetics at Albert Einstein College of Medicine; Jisella Dolan, Chief Global Advocacy Officer, Home Instead; Caitlin Donovan, Global Head,…